Table 2.
Adverse event | Prasugrel 60 mg LD/10 mg MD (n = 34), n (%) | Clopidogrel 600 mg LD/150 mg MD (n = 35), n (%) |
---|---|---|
Number of patients with at least one event | 5 (14.7) | 9 (25.7) |
Number of events | 8 | 19 |
Haematocrit decreaseda | 1 (2.9) | 0 |
Haemoglobin decreaseda | 1 (2.9) | 0 |
Headache | 1 (2.9) | 2 (5.7) |
Pain in extremity | 1 (2.9) | 0 |
Upper respiratory tract infection | 1 (2.9) | 1 (2.9) |
Urinary tract infection | 1 (2.9) | 0 |
Vessel puncture site haemorrhage | 1 (2.9) | 0 |
Contusion | 0 | 1 (2.9) |
Diarrhoea | 0 | 1 (2.9) |
Electrolyte imbalance | 0 | 1 (2.9) |
Epistaxis | 0 | 1 (2.9) |
Haemorrhage | 0 | 1 (2.9) |
Nausea | 0 | 1 (2.9) |
Respiratory tract congestion | 0 | 1 (2.9) |
Rhinorrhoea | 0 | 1 (2.9) |
Sinusitis | 0 | 1 (2.9) |
Vomiting | 0 | 1 (2.9) |
Wart excision | 0 | 1 (2.9) |
aInvestigator defined.